223 related articles for article (PubMed ID: 33125553)
1. Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography.
Zhu L; Guo J; Jin Z; Xue H; Dai M; Zhang W; Sun Z; Xu J; Marticorena Garcia SR; Asbach P; Hamm B; Sack I
Eur Radiol; 2021 May; 31(5):3366-3374. PubMed ID: 33125553
[TBL] [Abstract][Full Text] [Related]
2. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
[TBL] [Abstract][Full Text] [Related]
4. Tomoelastography for Measurement of Tumor Volume Related to Tissue Stiffness in Pancreatic Ductal Adenocarcinomas.
Marticorena Garcia SR; Zhu L; Gültekin E; Schmuck R; Burkhardt C; Bahra M; Geisel D; Shahryari M; Braun J; Hamm B; Jin ZY; Sack I; Guo J
Invest Radiol; 2020 Dec; 55(12):769-774. PubMed ID: 32796197
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
[TBL] [Abstract][Full Text] [Related]
7. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
8. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
[TBL] [Abstract][Full Text] [Related]
9. Multi-frequency magnetic resonance elastography of the pancreas: measurement reproducibility and variance among healthy volunteers.
Shi SY; Wang L; Peng Z; Wang Y; Lin Z; Hu X; Yuan J; Huang L; Feng ST; Luo Y
Gastroenterol Rep (Oxf); 2022; 10():goac033. PubMed ID: 35910246
[TBL] [Abstract][Full Text] [Related]
10. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
[TBL] [Abstract][Full Text] [Related]
11. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis.
Yoon SB; Jeon TY; Moon SH; Shin DW; Lee SM; Choi MH; Min JH; Kim MJ
Eur Radiol; 2023 Dec; 33(12):9010-9021. PubMed ID: 37466708
[TBL] [Abstract][Full Text] [Related]
14. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
[TBL] [Abstract][Full Text] [Related]
15. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
17. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
[TBL] [Abstract][Full Text] [Related]
18. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
[TBL] [Abstract][Full Text] [Related]
19. The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing.
Zhou W; Zhang D; Li Z; Jiang H; Li J; Ren R; Gao X; Li J; Wang X; Wang W; Yang Y
J Transl Med; 2021 May; 19(1):215. PubMed ID: 34006295
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune Pancreatitis Type 2: Diagnostic Utility of PD-L1 Immunohistochemistry.
Gupta R; Neyaz A; Chougule A; Akita M; Zen Y; Forcione D; Castillo CF; Ferrone CR; Deshpande V
Am J Surg Pathol; 2019 Jul; 43(7):898-906. PubMed ID: 31135488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
